CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $20,000 | -88.3% | 12,195 | -62.0% | 0.00% | – |
Q2 2023 | $170,250 | 0.0% | 32,062 | 0.0% | 0.00% | – |
Q1 2023 | $170,250 | -55.8% | 32,062 | -47.7% | 0.00% | – |
Q4 2022 | $385,353 | -99.9% | 61,362 | +2.2% | 0.00% | – |
Q3 2022 | $633,675,000 | +88.2% | 60,064 | -3.2% | 0.00% | – |
Q2 2022 | $336,758,000 | +21.1% | 62,018 | +104.7% | 0.00% | – |
Q1 2022 | $278,154,000 | – | 30,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |